Literature DB >> 26122369

Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy.

Douglas B Evans1, Ben George2, Susan Tsai3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26122369     DOI： 10.1245/s10434-015-4649-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  18 in total

Review 1.  FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

Authors:  Mustafa Suker; Berend R Beumer; Eran Sadot; Lysiane Marthey; Jason E Faris; Eric A Mellon; Bassel F El-Rayes; Andrea Wang-Gillam; Jill Lacy; Peter J Hosein; Sing Yu Moorcraft; Thierry Conroy; Florian Hohla; Peter Allen; Julien Taieb; Theodore S Hong; Ravi Shridhar; Ian Chau; Casper H van Eijck; Bas Groot Koerkamp
Journal:  Lancet Oncol       Date:  2016-05-06       Impact factor: 41.316

Review 2.  [Pancreatic ductal adenocarcinoma].

Authors:  E Gallmeier; T M Gress
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

3.  Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018.

Authors:  A J Hyde; R Nassabein; A AlShareef; D Armstrong; S Babak; S Berry; D Bossé; E Chen; B Colwell; C Essery; R Goel; R Goodwin; S Gray; N Hammad; A Jeyakuymar; D Jonker; P Karanicolas; N Lamond; R Letourneau; J Michael; N Patil; E Powell; R Ramjeesingh; W Saliba; R Singh; S Snow; T Stuckless; S Tadros; M Tehfé; M Thana; M Thirlwell; M Vickers; K Virik; S Welch; T Asmis
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

4.  Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.

Authors:  Jordan M Cloyd; Matthew H G Katz; Laura Prakash; Gauri R Varadhachary; Robert A Wolff; Rachna T Shroff; Milind Javle; David Fogelman; Michael Overman; Christopher H Crane; Eugene J Koay; Prajnan Das; Sunil Krishnan; Bruce D Minsky; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; William Ross; Priya Bhosale; Eric P Tamm; Huamin Wang; Anirban Maitra; Michael P Kim; Thomas A Aloia; Jean-Nicholas Vauthey; Jason B Fleming; James L Abbruzzese; Peter W T Pisters; Douglas B Evans; Jeffrey E Lee
Journal:  J Gastrointest Surg       Date:  2016-10-24       Impact factor: 3.452

Review 5.  Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations.

Authors:  Sophie Dobiasch; Nicole L Goerig; Rainer Fietkau; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2017-11-01       Impact factor: 3.621

6.  Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy: Focus on Hepatic Recurrence.

Authors:  Christopher W Mangieri; Cristian D Valenzuela; Richard A Erali; Perry Shen; Russell Howerton; Clancy J Clark
Journal:  Ann Surg Oncol       Date:  2022-02-20       Impact factor: 5.344

7.  Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

Authors:  Rebecca Y Kim; Kathleen K Christians; Mohammed Aldakkak; Callisia N Clarke; Ben George; Mandana Kamgar; Abdul H Khan; Naveen Kulkarni; William A Hall; Beth A Erickson; Douglas B Evans; Susan Tsai
Journal:  Ann Surg Oncol       Date:  2020-09-30       Impact factor: 5.344

8.  Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study.

Authors:  Sang Myung Woo; Min Kyeong Kim; Jungnam Joo; Kyong-Ah Yoon; Boram Park; Sang-Jae Park; Sung-Sik Han; Ju Hee Lee; Eun Kyung Hong; Yun-Hee Kim; Hae Moon; Sun-Young Kong; Tae Hyun Kim; Woo Jin Lee
Journal:  Cancer Res Treat       Date:  2017-01-19       Impact factor: 4.679

9.  Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study.

Authors:  Lei Huang; Lina Jansen; Yesilda Balavarca; Masoud Babaei; Lydia van der Geest; Valery Lemmens; Liesbet Van Eycken; Harlinde De Schutter; Tom B Johannesen; Maja Primic-Žakelj; Vesna Zadnik; Marc G Besselink; Petra Schrotz-King; Hermann Brenner
Journal:  BMC Med       Date:  2018-08-21       Impact factor: 8.775

10.  Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data.

Authors:  Doo-Ho Lee; Jin-Young Jang; Jae Seung Kang; Jae Ri Kim; Youngmin Han; Eunjung Kim; Wooil Kwon; Sun-Whe Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.